The Improvement of Black Raspberry in Obese and Mild AZ Patients Infected With H. Pylori
- Conditions
- Alzheimer DiseaseH Pylori Infection
- Interventions
- Dietary Supplement: Black raspberryOther: Placebo
- Registration Number
- NCT05680532
- Lead Sponsor
- Chung Shan Medical University
- Brief Summary
The current study was designed to check the impact of black raspberry (BR) on obese and mild Alzheimers (AZ) patients infected with Helicobacter pylori (H pylori). Through checking various parameters including anthropometric, antioxidants, and CDR.
- Detailed Description
The current study was designed to check the impact of black raspberry (BR) on obese and mild Alzheimers (AZ) patients infected with Helicobacter pylori (H pylori).
Preclinical studies (In vitro model) were conducted using 3T3-L1 adipocyte cells to check the anti-adhesion activity of BR.
For the clinical trial, a total of 21 obese mild AZ patients were recruited and separated into 2 groups: Experimental (BR group) and Placebo group.
Experimental group and Placebo group subjects were requested to take either 50 g of BR or 50 g of dextrin respectively for 4 weeks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 21
- BMI ≧ 27, Waist circumference: men ≧ 90cm, women ≧ 80cm,
- Body fat: male ≧ 25%, female ≧ 30%,
- UBT 13C test value> 10‰ (H. pylori (+)),
- CDR (clinical dementia rating) = 0.5
- BMI< 27
- Severe chronic diseases (liver disease, cardiovascular disease, kidney disease)
- Alcohol abuse
- Smoking habit
- Taking berry-related supplementation or any known allergies related to berries.
- Subjects with prior history of H. pylori infection were treated with triple therapy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description BR group Black raspberry Experimental group AZ subjects were requested to take 50 g of BR powder dissolved in 240 ml of water for 4 weeks. Placebo group Placebo Placebo group AZ subjects were requested to take 50 g of dextrin powder dissolved in 240 ml of water for 4 weeks.
- Primary Outcome Measures
Name Time Method Glycemic indices 8 weeks No significant changes in any of the glycemic indices
Anthropometric parameters 8 weeks BMI were significantly altered
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chung Shan Medical University
🇨🇳Taichung city, Taichung, Taiwan